SFEBES2025 Poster Presentations Thyroid (41 abstracts)
1Endocrinology, Salford Royal Hospital, Northern Care Alliance Foundation Trust, Salford, United Kingdom; 2Faculty of Biology, Medicine and Health, University of Manchester, Salford, United Kingdom
Autoimmune Polyglandular Syndromes (APS) are rare disorders characterised by immune-mediated multi-organ dysfunctions. The three main subtypes, APS-1, APS-2, and APS-3 are distinguished by different patterns of endocrine involvement. Mutations in the autoimmune regulator (AIRE) gene on chromosome 21q22.3 that impair thymic immune tolerance causes APS-1, which is strongly associated with autoimmune hypoparathyroidism (90% of cases), chronic mucocutaneous candidiasis and adrenal insufficiency. It can also involve type 1 diabetes, hypothyroidism, pernicious anaemia, vitiligo, hepatitis, oophoritis and keratitis. Recent evidence suggests that existing diagnostic criteria may be inadequate, as not all patients with APS-1 exhibit classical features. We present a woman (index case) with chronic hypocalcaemia due to hypoparathyroidism since birth, type 1 diabetes from age 10 years and autoimmune hypothyroidism in her forties. Her younger sister also has chronic hypoparathyroidism with hypocalcaemia, and hypothyroidism. There is a family history of thyroid dysfunction in another sister, a brother, and their mother. These findings suggest a potential hereditary polyglandular deficiency pattern that does not fully fit the diagnosis of APS-1. It raises the possibility of either a non-classical/variant form of the syndrome, an unidentified gene mutation or a different type of polyglandular syndrome which is yet to be classified. It underscores the heterogeneity of APS, revealing gaps in our understanding of its genetic and phenotypic spectrum.
PTH (2.0 - 9.3) pmol/L | Parathyroid Antibodies | Adjusted calcium (2.20 - 2.60) mmol/L* | Urinary calcium Excretion Index (0.013 - 0.037) mmol/L | Vitamin D (50.0 - 125.0) nmol/L | Thyroid Peroxidase Antibody (< 35) IU/mL | Islet Cell Antibody | Anti-GAD antibody (< 5.0) U/mL | AIRE gene mutation | |
Index case | 1.2 -3 | Negative | 1.86 - 2.19 | 0.052 | 79 - 99.6 | > 1000 | Positive | > 2000 | Absent |
Sibling case | 1.5 - 3.2 | Not tested | 2.08 - 2.19 | 0.041 | 55.6 - 96.9 | 15 (< 35) | N/A | N/A | Awaited |
*Prior to endocrine review. N/A, not applicable |